Home
About
Overview
Sharing Data
ORCID
Help
History (5)
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome.
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX).
Fragile X: leading the way for targeted treatments in autism.
Implementation of a markerless motion analysis method to quantify hyperkinesis in males with fragile X syndrome.
Neuropathic features in fragile X premutation carriers.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Neuropathic features in fragile X premutation carriers.
Neuropathic features in fragile X premutation carriers. Am J Med Genet A. 2007 Jan 01; 143A(1):19-26.
View in:
PubMed
subject areas
Female
Fragile X Mental Retardation Protein
Fragile X Syndrome
Heterozygote
Humans
Male
Mass Screening
Peripheral Nervous System Diseases
Phenotype
Trinucleotide Repeat Expansion
authors with profiles
Deborah A Hall
Elizabeth M Berry-Kravis